You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Emtricitabine tenofovir alafenamide

Showing 1 - 25 of 1,145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

Not yet recruiting
  • HIV Infection
  • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
  • (no location specified)
Aug 8, 2023

Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir

Completed
  • Hiv
  • Hormone Therapy
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
  • Emtricitabine Tenofovir Alafenamide 200/25 mg
  • San Diego, California
    UC San Diego AntiViral Research Center (AVRC)
Sep 21, 2022

HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)

Not yet recruiting
  • HIV Infections
  • Biktarvy 50 mg/200 mg/25 mg film-coated tablets
  • Barcelona, Spain
    Hospital Clinic i Provincial Barcelona
Oct 26, 2022

HIV, Obesity Trial in Greenville (Biktarvy, Symtuza)

Not yet recruiting
  • HIV Infections
  • Obesity
  • Greenville, North Carolina
    Adult Specialty Care Clinic-East Carolina University
Jul 14, 2022

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • (no location specified)
Aug 4, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Dec 19, 2022

HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)

Completed
  • HIV-1-infection
  • Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
  • San Francisco, California
    SFOMG Private Practice
Jan 27, 2022

Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir

Recruiting
  • Acceptability of Health Care
  • Adherence, Medication
  • emtricitabine/tenofovir alafenamide
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet
  • Durban, KZN, South Africa
  • +2 more
Jul 12, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • Montréal, Canada
  • +5 more
Sep 22, 2022

Drug Interaction Trial in Bangkok (Estradiol valerate 2 mg, cyproterone acetate 25 mg)

Active, not recruiting
  • Drug Interaction
  • Estradiol valerate 2 mg, cyproterone acetate 25 mg
  • Bangkok, Pathumwan, Thailand
    Institute of HIV Research and Innovation (IHRI)
Oct 19, 2022

HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Recruiting
  • HIV Infections
  • Renal Transplant Rejection
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • B/F/TAF
  • Haifa, Israel
  • +4 more
Mar 8, 2022

HIV Prevention Trial in Boston (bictegravir)

Completed
  • HIV Prevention
  • Boston, Massachusetts
    Fenway Community Health
Apr 6, 2022

Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)

Recruiting
  • Hiv
  • Transgenderism
  • Biktarvy 50/200/25 Tab
  • Estradiol Tablets
  • Toronto, Ontario, Canada
    Maple Leaf Research
Dec 15, 2022

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Completed
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021

HIV Trial (DTG/3TC)

Not yet recruiting
  • HIV
  • (no location specified)
Jun 9, 2023

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

Active, not recruiting
  • HIV I Infection
  • Dolutegravir / Lamivudine Pill
  • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

Healthy Volunteers Trial in Baltimore (Genvoya Oral dose, Genvoya Crushed Dose)

Completed
  • Healthy Volunteers
  • Genvoya Oral dose
  • Genvoya Crushed Dose
  • Baltimore, Maryland
    Johns Hopkins University
Nov 9, 2021

HIV Trial in Madrid (Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY])

Not yet recruiting
  • HIV Infections
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Madrid, Spain
    H. Infanta Leonor
Jun 2, 2022

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022